Business Description
PharmaNutra SpA
ISIN : IT0005274094
Compare
Compare
Traded in other countries / regions
PHN.Italy761.GermanyPHNm.UK IPO Date
2021-07-22Description
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, Asia, and others.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.76 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.5 | |||||
Debt-to-EBITDA | 1.14 | |||||
Interest Coverage | 21.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 6.44 | |||||
Beneish M-Score | -2.5 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.2 | |||||
3-Year EBITDA Growth Rate | 19.2 | |||||
3-Year EPS without NRI Growth Rate | -3.3 | |||||
3-Year Book Growth Rate | 13.2 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | 2.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.15 | |||||
Quick Ratio | 1.87 | |||||
Cash Ratio | 0.74 | |||||
Days Inventory | 41.01 | |||||
Days Sales Outstanding | 83.48 | |||||
Days Payable | 77.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.72 | |||||
3-Year Dividend Growth Rate | 20.3 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | -0.75 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 31.76 | |||||
Operating Margin % | 20.91 | |||||
Net Margin % | 10.65 | |||||
FCF Margin % | 1.5 | |||||
ROE % | 20.34 | |||||
ROA % | 9.94 | |||||
ROIC % | 15.52 | |||||
ROC (Joel Greenblatt) % | 57.42 | |||||
ROCE % | 26.88 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 41.12 | |||||
PE Ratio without NRI | 41.19 | |||||
PEG Ratio | 2.26 | |||||
PS Ratio | 4.39 | |||||
PB Ratio | 7.77 | |||||
Price-to-Tangible-Book | 12.98 | |||||
Price-to-Free-Cash-Flow | 302.96 | |||||
Price-to-Operating-Cash-Flow | 37.5 | |||||
EV-to-EBIT | 20.43 | |||||
EV-to-EBITDA | 18.1 | |||||
EV-to-Revenue | 4.42 | |||||
EV-to-FCF | 294.79 | |||||
Price-to-Projected-FCF | 6.92 | |||||
Price-to-Graham-Number | 4.87 | |||||
Price-to-Net-Current-Asset-Value | 107.09 | |||||
Earnings Yield (Greenblatt) % | 4.89 | |||||
FCF Yield % | 0.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PharmaNutra SpA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 101.691 | ||
EPS (TTM) (€) | 1.12 | ||
Beta | 0 | ||
Volatility % | 8.66 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0.000007 | ||
20-Day SMA (€) | 62.6 | ||
12-1 Month Momentum % | 2.96 | ||
52-Week Range (€) | 62.6 - 62.6 | ||
Shares Outstanding (Mil) | 9.61 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PharmaNutra SpA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PharmaNutra SpA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
PharmaNutra SpA Frequently Asked Questions
What is PharmaNutra SpA(CHIX:PHNm)'s stock price today?
The current price of CHIX:PHNm is €62.60. The 52 week high of CHIX:PHNm is €62.60 and 52 week low is €62.60.
When is next earnings date of PharmaNutra SpA(CHIX:PHNm)?
The next earnings date of PharmaNutra SpA(CHIX:PHNm) is .
Does PharmaNutra SpA(CHIX:PHNm) pay dividends? If so, how much?
PharmaNutra SpA(CHIX:PHNm) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |